Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study
Titel:
Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study
Auteur:
Younes, Anas Thieblemont, Catherine Morschhauser, Franck Flinn, Ian Friedberg, Jonathan W Amorim, Sandy Hivert, Benedicte Westin, Jason Vermeulen, Jessica Bandyopadhyay, Nibedita de Vries, Ronald Balasubramanian, Sriram Hellemans, Peter Smit, Johan W Fourneau, Nele Oki, Yasuhiro